Skip to main content

Adenosine Injection Shortage

Last Updated: May 14, 2025
Status: Current

Products Affected - Description
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0318-04
Reason for the Shortage
    • Akorn ceased operations in February 2023.
    • Pfizer discontinued adenosine in late-2022.
    • Eugia has adenosine injection available.
    • Fresenius Kabi has adenosine injection available.
    • Sagent did not provide a reason for the shortage.
    • Teva is not currently marketing adenosine injection.
    • Viatris has adenosine injection available.
Available Products
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 20 mL vial, 1 count, NDC 55150-0192-01
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 30 mL vial, 1 count, NDC 55150-0193-01
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 20 mL vial, 1 count, NDC 63323-0651-20
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 30 mL vial, 1 count, NDC 63323-0651-30
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 20 mL vial, 1 count, NDC 67457-0856-20
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 30 mL vial, 1 count, NDC 67457-0857-30
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL syringe, 10 count, NDC 63323-0651-89
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL syringe, 10 count, NDC 63323-0651-90
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 2 mL vial, 10 count, NDC 67457-0855-02
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 4 mL vial, 10 count, NDC 67457-0854-04
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0318-02

Estimated Resupply Dates

    • Sagent has adenosine 3 mg/mL 2 mL and 4 mL syringes and 3 mg/mL 4 mL vials on back order and the company estimates a release date of May 2025 for the 2 mL syringes, June 2025 for the 4 mL vials, and July 2025 for the 4 mL syringes.

Updated

Updated May 14, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 3, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.